“We are excited to finalize this new technology for such a significant problem that affects the health of millions of people around globe,” said Dr. Fatemeh Shirazi, CEO of Microvi. “Our commitment to our customers in the drinking water industry has always been to offer the most reliable, advanced, safe, and cost-effective treatment technologies.”
Read MoreThe talk, entitled “Bioprocess development for 1,4-dioxane treatment: Bench through field investigation,” will be delivered by Microvi’s Director of Innovation Research Ameen Razavi. It explores the challenges of dioxane remediation.
Read More